HAVAH THERAPEUTICS
Originally founded in Australia in 2006, Palo Alto-based HAVAH Therapeutics Inc. is a clinical-stage pharmaceutical company specialising in the development of novel therapeutics for the prevention of breast cancer. Breast cancer prevention is a critical, unmet global need. HAVAH's lead product candidate, T+Ai, is a proprietary breakthrough breast cancer prevention combination therapy - reducing a womanโs risk of breast cancer whilst improving their sense of wellbeing.
HAVAH THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.havahtx.com
Total Employee:
1+
Status:
Active
Contact:
(650)799-4635
Email Addresses:
[email protected]
Total Funding:
1000 K AUD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Stephen Birrell
Stephen Birrell Founder and Chief Medical Officer @ HAVAH Therapeutics Founder and Chief Medical Officer 2005-01-01
Ronald Martell
Ronald Martell Executive Director @ HAVAH Therapeutics Executive Director 2017-01-01
Nicholas Birrell
Nicholas Birrell Co-founder | CEO @ HAVAH Therapeutics Co-founder | CEO 2012-01-01
Founder
Nicholas Birrell
Stephen Birrell
Official Site Inspections
http://www.havahtx.com
- Host name: 221.249.213.35.bc.googleusercontent.com
- IP address: 35.213.249.221
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
Loading ...